Adefowope Odueyungbo
About Adefowope Odueyungbo
Adefowope Odueyungbo is the Director and Head of Biometrics at Fulcrum Therapeutics in Cambridge, Massachusetts. He has a strong background in biostatistics, having previously held positions at Roche and Merrimack.
Current Role at Fulcrum Therapeutics
Adefowope Odueyungbo serves as the Director and Head of Biometrics at Fulcrum Therapeutics. He has held this position since 2019, contributing to the company's efforts in developing innovative therapies. His role involves overseeing biometrics operations, ensuring the integrity and accuracy of data analysis in clinical trials. Fulcrum Therapeutics is based in Cambridge, Massachusetts, where Odueyungbo applies his extensive experience in biostatistics and biometrics.
Previous Experience at Roche
Prior to his current role, Odueyungbo worked at Roche in various capacities. He was an Associate Director of Biostatistics for a brief period in 2019. Before that, he served as a Biometrics Team Leader from 2018 to 2019 and as a Project Lead Statistician from 2016 to 2019. His tenure at Roche took place in Mississauga, Ontario, Canada, where he managed teams and projects focused on statistical analysis in clinical research.
Biostatistics Role at Merrimack
Odueyungbo worked as a Principal Biostatistician at Merrimack from 2012 to 2014. During his time in Cambridge, Massachusetts, he was responsible for statistical analysis and contributed to the design and interpretation of clinical trials. This role further solidified his expertise in biostatistics and data management within the pharmaceutical industry.
Educational Background
Adefowope Odueyungbo has a strong academic background in the field of statistics and biostatistics. He earned a Bachelor of Science degree from Obafemi Awolowo University between 1997 and 2002. He then pursued a Master of Science degree at the University of Calgary from 2004 to 2006. Furthering his education, he completed a Doctor of Philosophy at McMaster University from 2006 to 2009. This educational foundation supports his professional expertise in biometrics and clinical research.